Autologous endothelial progenitor cells transplantation for the therapy of primary pulmonary hypertension

Medical Hypotheses

Volumn 68, Issue 6, 2007, Pages 1292-1295

  Zeng, Chunlai ^a   Wang, Xinxiang ^a   Hu, Xiaosheng ^a   Chen, Junzhu ^a   Wang, Lexin ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL MIGRATION; DISEASE MODEL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART RIGHT VENTRICLE FAILURE; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVASCULARIZATION; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, PULMONARY; MODELS, BIOLOGICAL; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947680314     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.062     Document Type: Article

References (37)

1. Rubin L.J. Current concepts: primary pulmonary hypertension. N Engl J Med 336 (1997) 111-117
2. Chazova I., Loyd J.E., Zhdanov V.S., et al. Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. Am J Pathol 146 (1995) 389-397
3. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 107 (1987) 216-230
4. D'alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension: results of a national prospective registry. Ann Intern Med 11 (1991) 343-349
5. Hertz M.I., Taylor D.O., Trulock E.P., et al. The registry of the International Society for Heart and Lung Transplantation: Nineteenth Official Report 2002. J Heart Lung Transpl 21 (2002) 950-970
6. Galie N., Manes A., and Branzi A. Prostanoids for pulmonary arterial hypertension. Am J Resp Med 2 (2003) 123-137
7. Galie N., Manes A., and Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61 (2004) 227-237
8. Sastry B.K.S., Narasimhan C., Reddy N.K., et al. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43 (2004) 1149-1153
9. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
10. Takahashi T., Kalka C., Masuda H., et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
11. Cines D.B., Pollak E.S., Buck C.A., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561
12. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharm 22 Suppl. (1993) S1-S4
13. Christman B.W., McPherson C.D., Newman J.H., King G.A., and Bernard G.R. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327 (1992) 70-75
14. Giaid A., and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333 (1995) 214-221
15. Humbert M., Morrell N.W., Archer S.L., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43 Suppl. 12 (2004) 13S-24S
16. Giaid A., Yanagisawa M., Langleben D., et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328 (1993) 1732-1739
17. White C.R., Darley-Usmar V., Berrington W.R., et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci 93 (1996) 8745-8749
18. Cowan K.N., Jones P.L., and Rabinovitch M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105 (2000) 21-34
19. Bombeli T., Mueller M., and Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemostasis 77 (1997) 408-423
20. Ruf A., and Morgenstern E. Ultrastructural aspects of platelet adhesion on subendothelial structures. Semin Thromb Hemost 21 (1995) 119-122
21. Frank H., Mlczoch J., Huber K., et al. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 112 (1997) 714-721
22. Welsh C.H., Hassell K.L., Badesch D.B., et al. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest 110 (1996) 710-717
23. Wright L., Tuder R.M., Wang J., et al. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Resp Crit Care 157 (1998) 219-229
24. Fartoukh M., Emilie D., Le Gall C., et al. Chemokine macrophage inflammatory protein-1mRNA expression in lung biopsy specimens of primary pulmonary hypertension. Chest 114 (1998) 50S-51S
25. Humbert M., Monti G., Brenot F., et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Resp Crit Care 151 (1995) 1628-1631
26. Risau W., and Flamme I. Vasculogenesis. Annu Rev Cell Dev Bi 11 (1995) 73
27. Folkman J. Clinical applications of research in angiogenesis. N Engl J Med 333 (1995) 1757
28. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
29. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
30. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
31. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
32. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
33. Bompais H., Chagraoui J., Canron X., et al. Human endothelial cells derived from circulating progenitors display specific functional properties as compared to mature vessel wall endothelial cells. Blood 103 (2004) 2577-2584
34. Nagaya N., Kangawa K., Kanda M., and Uematsu M. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 108 (2003) 889-895
35. Yidan D., David W., Yupu D., et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96 (2005) 442-450
36. Mattocks A.R., Jukes R., and Brown J. Simple procedures for preparing putative metabolites of pyrrolizidine alkaloids. Toxicon 27 (1989) 561-567
37. Asahara T.H., Masuda T., Takahashi C., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228